Cargando…

Development of a predictive model for stromal content in prostate cancer samples to improve signature performance

Prostate cancer is heterogeneous in both cellular composition and patient outcome, and development of biomarker signatures to distinguish indolent from aggressive tumours is a high priority. Stroma plays an important role during prostate cancer progression and undergoes histological and transcriptio...

Descripción completa

Detalles Bibliográficos
Autores principales:	Boufaied, Nadia, Takhar, Mandeep, Nash, Claire, Erho, Nicholas, Bismar, Tarek A, Davicioni, Elai, Thomson, Axel A
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley & Sons, Ltd 2019
Materias:	Original Papers
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6900085/ https://www.ncbi.nlm.nih.gov/pubmed/31206668 http://dx.doi.org/10.1002/path.5315

Ejemplares similares

Characterization of transcriptomic signature of primary prostate cancer analogous to prostatic small cell neuroendocrine carcinoma
por: Alshalalfa, Mohammed, et al.
Publicado: (2019)

Gene expression signatures of neuroendocrine prostate cancer and primary small cell prostatic carcinoma
por: Tsai, Harrison K., et al.
Publicado: (2017)

Evolving transcriptomic fingerprint based on genome‐wide data as prognostic tools in prostate cancer
por: Alshalalfa, Mohammed, et al.
Publicado: (2015)

Transcriptome-Wide Detection of Differentially Expressed Coding and Non-Coding Transcripts and Their Clinical Significance in Prostate Cancer
por: Erho, Nicholas, et al.
Publicado: (2012)

Genomic “Dark Matter” in Prostate Cancer: Exploring the Clinical Utility of ncRNA as Biomarkers
por: Vergara, Ismael A., et al.
Publicado: (2012)

Genome-wide analysis of androgen receptor binding and transcriptomic analysis in mesenchymal subsets during prostate development
por: Nash, Claire, et al.
Publicado: (2019)

Association of multiparametric MRI quantitative imaging features with prostate cancer gene expression in MRI-targeted prostate biopsies
por: Stoyanova, Radka, et al.
Publicado: (2016)

Impact of the SPOP Mutant Subtype on the Interpretation of Clinical Parameters in Prostate Cancer
por: Liu, Deli, et al.
Publicado: (2018)

Lipid degradation promotes prostate cancer cell survival
por: Itkonen, Harri M, et al.
Publicado: (2017)

Distinct transcriptional repertoire of the androgen receptor in ETS fusion-negative prostate cancer
por: Berglund, Anders E., et al.
Publicado: (2018)

Asporin is a stromally expressed marker associated with prostate cancer progression
por: Rochette, Annie, et al.
Publicado: (2017)

Development and Validation of a 28-gene Hypoxia-related Prognostic Signature for Localized Prostate Cancer
por: Yang, Lingjian, et al.
Publicado: (2018)

Identification of genes expressed in a mesenchymal subset regulating prostate organogenesis using tissue and single cell transcriptomics
por: Boufaied, Nadia, et al.
Publicado: (2017)

DNA methylation signatures of Prostate Cancer in peripheral T-cells
por: Mehdi, Ali, et al.
Publicado: (2020)

The long noncoding RNA landscape of neuroendocrine prostate cancer and its clinical implications
por: Ramnarine, Varune Rohan, et al.
Publicado: (2018)

Discovery and Validation of Novel Expression Signature for Postcystectomy Recurrence in High-Risk Bladder Cancer
por: Mitra, Anirban P., et al.
Publicado: (2014)

Therapy-induced developmental reprogramming of prostate cancer cells and acquired therapy resistance
por: Nouri, Mannan, et al.
Publicado: (2017)

Prostate cancer in young men represents a distinct clinical phenotype: gene expression signature to predict early metastases
por: Ding, Yuan C., et al.
Publicado: (2021)

Genomic and epigenomic analysis of high-risk prostate cancer reveals changes in hydroxymethylation and TET1
por: Spans, Lien, et al.
Publicado: (2016)

Prostate Cancer Tumor Volume and Genomic Risk
por: Ramaswamy, Ashwin, et al.
Publicado: (2023)

Editorial: The Application of Proteogenomics to Urine Analysis for the Identification of Novel Biomarkers of Prostate Cancer: An Exploratory Study
por: Gamallat, Yaser, et al.
Publicado: (2023)

Metagenomic and metatranscriptomic analysis of human prostate microbiota from patients with prostate cancer
por: Feng, Ye, et al.
Publicado: (2019)

Characterization of Matricellular Protein Expression Signatures in Mechanistically Diverse Mouse Models of Kidney Injury
por: Feng, Daniel, et al.
Publicado: (2019)

Discovery and Validation of a Prostate Cancer Genomic Classifier that Predicts Early Metastasis Following Radical Prostatectomy
por: Erho, Nicholas, et al.
Publicado: (2013)

Coordinate MicroRNA-Mediated Regulation of Protein Complexes in Prostate Cancer
por: Alshalalfa, Mohammed, et al.
Publicado: (2013)

High-fat diet fuels prostate cancer progression by rewiring the metabolome and amplifying the MYC program
por: Labbé, David P., et al.
Publicado: (2019)

Cleavage and Polyadenylation-Specific Factor 4 (CPSF4) Expression Is Associated with Enhanced Prostate Cancer Cell Migration and Cell Cycle Dysregulation, In Vitro
por: Choudhry, Muhammad, et al.
Publicado: (2023)

Low PCA3 expression is a marker of poor differentiation in localized prostate tumors: exploratory analysis from 12,076 patients
por: Alshalalfa, Mohammed, et al.
Publicado: (2017)

ERG Protein Expression Is of Limited Prognostic Value in Men with Localized Prostate Cancer
por: Teng, Liang Hong, et al.
Publicado: (2013)

Potential Impact on Clinical Decision Making via a Genome-Wide Expression Profiling: A Case Report
por: Kim, Hyun, et al.
Publicado: (2016)

Validation of the Decipher Test for predicting adverse pathology in candidates for prostate cancer active surveillance
por: Kim, Hyung L., et al.
Publicado: (2018)

Radiogenomic profiling of prostate tumors prior to external beam radiotherapy converges on a transcriptomic signature of TGF-β activity driving tumor recurrence
por: Ku, Anson T., et al.
Publicado: (2023)

Patient-derived bladder cancer xenografts in the preclinical development of novel targeted therapies
por: Jäger, Wolfgang, et al.
Publicado: (2015)

Investigation of androgen receptor-dependent alternative splicing has identified a unique subtype of lethal prostate cancer
por: Seltzer, Sean, et al.
Publicado: (2022)

The oestrogen receptor alpha-regulated lncRNA NEAT1 is a critical modulator of prostate cancer
por: Chakravarty, Dimple, et al.
Publicado: (2014)

Effect of a genomic classifier test on clinical practice decisions for patients with high-risk prostate cancer after surgery
por: Badani, Ketan K, et al.
Publicado: (2015)

Impact of a genomic classifier of metastatic risk on postoperative treatment recommendations for prostate cancer patients: a report from the DECIDE study group
por: Badani, Ketan, et al.
Publicado: (2013)

Glycyl-tRNA Synthetase (GARS) Expression Is Associated with Prostate Cancer Progression and Its Inhibition Decreases Migration, and Invasion In Vitro
por: Khosh Kish, Ealia, et al.
Publicado: (2023)

Analysing the tumor transcriptome of prostate cancer to predict efficacy of Lu-PSMA therapy
por: Handke, Analena, et al.
Publicado: (2023)

MYC drives aggressive prostate cancer by disrupting transcriptional pause release at androgen receptor targets
por: Qiu, Xintao, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_2q1t7bq6gu2ane1kk8kggdr036